Characteristics of United States Counties in Which Heart Failure Clinical Trials of Pharmacotherapy Were Conducted

被引:2
|
作者
Cox, Elisabeth [1 ]
Alsalloum, Muath A. [1 ,2 ]
Vander Schaaf, Marin [1 ]
Alfehaid, Abdulaziz S. [1 ,3 ]
Alnewais, Marwah E. [1 ,4 ]
Weeda, Erin R. [1 ,5 ]
机构
[1] Med Univ South Carolina, Coll Pharm, Charleston, SC USA
[2] Imam Abdulrahman Bin Faisal Univ, Coll Clin Pharm, Dept Pharm Practice, Dammam, Saudi Arabia
[3] King Faisal Gen Hosp, Pharmaceut Care Serv, Alahsa Hlth Cluster, Minist Hlth, Al Hufuf, Saudi Arabia
[4] King Faisal Univ, Coll Clin Pharm, Alahsa, Saudi Arabia
[5] Med Univ South Carolina, Dept Clin Pharm & Outcomes Sci, 280 Calhoun St,QE213C MSC140, Charleston, SC 29425 USA
关键词
applicability; clinical trials; diversity; external validity; generalizable; rural; social determinants of health;
D O I
10.1161/CIRCHEARTFAILURE.122.010449
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Turning Failure into Success: Trials of the Heart Failure Clinical Research Network
    Emer Joyce
    Michael M. Givertz
    Current Cardiology Reports, 2016, 18
  • [22] Site selection for heart failure clinical trials in the USA
    Matthew E. Harinstein
    Javed Butler
    Stephen J. Greene
    Gregg C. Fonarow
    Norman L. Stockbridge
    Christopher M. O’Connor
    Marc A. Pfeffer
    Mandeep R. Mehra
    Scott D. Solomon
    Clyde W. Yancy
    Mona Fiuzat
    Robert J. Mentz
    Sean P. Collins
    John J. V. McMurray
    Muthiah Vaduganathan
    Preston M. Dunnmon
    Giuseppe M. C. Rosano
    Wilfried Dinh
    Frank Misselwitz
    Robert O. Bonow
    Mihai Gheorghiade
    Heart Failure Reviews, 2015, 20 : 375 - 383
  • [23] Rufinamide from clinical trials to clinical practice in the United States and Europe
    Resnick, Trevor
    Arzimanoglou, Alexis
    Brown, Lawrence W.
    Flamini, Robert
    Kerr, Michael
    Kluger, Gerhard
    Kothare, Sanjeev
    Philip, Sunny
    Harrison, Miranda
    Narurkar, Milind
    EPILEPTIC DISORDERS, 2011, 13 : S27 - S43
  • [24] Turning Failure into Success: Trials of the Heart Failure Clinical Research Network
    Joyce, Emer
    Givertz, Michael M.
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (12)
  • [25] Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition
    Zannad, Faiez
    Stough, Wendy Gattis
    Pitt, Bertram
    Cleland, John G. F.
    Adams, Kirkwood F.
    Geller, Nancy L.
    Torp-Pedersen, Christian
    Kirwan, Bridget-Anne
    Follath, Ferenc
    EUROPEAN HEART JOURNAL, 2008, 29 (03) : 413 - 421
  • [26] The landscape of precision cancer medicine clinical trials in the United States
    Roper, Nitin
    Stensland, Kristian D.
    Hendricks, Ryan
    Galsky, Matthew D.
    CANCER TREATMENT REVIEWS, 2015, 41 (05) : 385 - 390
  • [27] Why the United States Needs a Network for Stroke Clinical Trials
    Landis, Story
    Fisher, Marc
    STROKE, 2013, 44 (05) : 1217 - 1218
  • [28] Regional Variation in HIV Clinical Trials Participation in the United States
    Heumann, Christine
    Cohn, Susan E.
    Krishnan, Supriya
    Castillo-Mancilla, Jose R.
    Cespedes, Michelle
    Floris-Moore, Michelle
    Smith, Kimberly Y.
    SOUTHERN MEDICAL JOURNAL, 2015, 108 (02) : 107 - 116
  • [29] Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative
    Mikita, J. Stephen
    Mitchel, Jules
    Gatto, Nicolle M.
    Laschinger, John
    Tcheng, James E.
    Zeitler, Emily P.
    Swern, Arlene S.
    Flick, E. Dawn
    Dowd, Christopher
    Lystig, Theodore
    Calvert, Sara B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 6 - 18
  • [30] Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative
    J. Stephen Mikita
    Jules Mitchel
    Nicolle M. Gatto
    John Laschinger
    James E. Tcheng
    Emily P. Zeitler
    Arlene S. Swern
    E. Dawn Flick
    Christopher Dowd
    Theodore Lystig
    Sara B. Calvert
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 6 - 18